Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 11958664)

1.

Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.

Van Cott EM, Soderberg BL, Laposata M.

Arch Pathol Lab Med. 2002 May;126(5):577-82. Review.

PMID:
11958664
2.

Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.

Nicolaes GA, Dahlbäck B.

Hematol Oncol Clin North Am. 2003 Feb;17(1):37-61, vi. Review.

PMID:
12627662
3.

Activated protein C resistance--a major risk factor for thrombosis.

Rosén SB, Sturk A.

Eur J Clin Chem Clin Biochem. 1997 Jul;35(7):501-16. Review.

PMID:
9263726
4.

Activated protein C resistance and factor V Leiden: a review.

Rosendorff A, Dorfman DM.

Arch Pathol Lab Med. 2007 Jun;131(6):866-71. Review.

PMID:
17550313
5.

[From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].

Reitsma PH, van de Stolpe A.

Ned Tijdschr Geneeskd. 2001 Sep 22;145(38):1843-5. Review. Dutch.

PMID:
11593787
6.

Resistance to activated protein C--frequent etiologic factor for venous thrombosis.

Simkova M, Simko F, Kovacs L.

Bratisl Lek Listy. 2001;102(5):240-7. Review.

PMID:
11725376
7.

Resistance to activated protein C and a novel factor V gene mutation.

Voelkerding KV.

Clin Lab Med. 1996 Mar;16(1):169-86. Review.

PMID:
8867589
8.

Factor V Leiden: a disorder of factor V anticoagulant function.

Castoldi E, Rosing J.

Curr Opin Hematol. 2004 May;11(3):176-81. Review.

PMID:
15257017
9.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
10.

[National evaluation of the diagnosis of activated protein C resistance].

Montiel-Manzano G, de la Peña-Díaz A, Majluf-Cruz A, Cesarman-Maus G, Corona-de la Peña N, Cruz-Cruz D, Gaminio E, Martínez-Murillo C, Mayagoitia T, Miranda-Peralta E, Poblete T, Quintana-Martínez S, Ramírez R, Razo D, Ruiz de Chávez-Ochoa A, Reyes-Núñez VA, Salazar R, Vicencio-Santiago GV, Villa R.

Rev Invest Clin. 2003 May-Jun;55(3):358-69. Review. Spanish. Erratum in: Rev Invest Clin. 2003 Sep-Oct;55(5):583. Reyes-Núñez Aurelia Virginia [corrected to Reyes-Núñez Virginia Adriana].

PMID:
14515684
11.
12.

The discovery of activated protein C resistance.

Dahlbäck B.

J Thromb Haemost. 2003 Jan;1(1):3-9. Review.

PMID:
12871530
13.

Obstetric implications of activated protein C resistance and factor V Leiden mutation.

Gherman RB, Goodwin TM.

Obstet Gynecol Surv. 2000 Feb;55(2):117-22. Review.

PMID:
10674255
14.

Venous thromboembolic disease: risk factors and laboratory investigation.

Alhenc-Gelas M, Aiach M, de Moerloose P.

Semin Vasc Med. 2001;1(1):81-8. Review.

PMID:
15199517
15.

Resistance to activated protein C: a major cause of inherited thrombophilia.

Jensen R, Ens GE.

Clin Lab Sci. 1997 Jul-Aug;10(4):219-22. Review.

PMID:
10169621
16.

Coagulation factor V and thrombophilia: background and mechanisms.

Segers K, Dahlbäck B, Nicolaes GA.

Thromb Haemost. 2007 Sep;98(3):530-42. Review.

PMID:
17849041
17.

Cardiovascular implications of the factor V Leiden mutation.

Major DA, Sane DC, Herrington DM.

Am Heart J. 2000 Aug;140(2):189-95. Review. No abstract available.

PMID:
10925328
18.

[Factor V Leiden and activated protein C resistance].

Cauchie P, Hilbert P.

Rev Med Brux. 1997 Jun;18(3):97-102. Review. French.

PMID:
9273603
19.

Factor V Leiden: an overview.

Shaw DM.

Clin Lab Sci. 2006 Fall;19(4):218-21. Review.

PMID:
17181126
20.

Utility of testing for factor V Leiden.

Franchini M.

Blood Transfus. 2012 Jul;10(3):257-9. doi: 10.2450/2012.0095-12. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk